• Cancer and genetic diseases

    affect more than 30 million people 

    Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence.

    15%

    of all disease causing mutations are predicted to disrupt RNA splicing

    370

    known genetic disorders in publications are caused by RNA splicing errors

    50%

    of synonymous cancer-driver mutations impair RNA splicing

  • SpliceCore

    Artificial Intelligence Platform for Drug Discovery

  • Investors

    Third Kind Venture Capital
    Dolby Family Ventures
    Empire State Development
    Accelerate Long Island
    Dynamk Capital
    SBIR
    Topspin
    Breakout Labs
    National Institutes of Health
    SV Angel
  • Partners

    Amazon Web Services
    Google Cloud Platform
    Microsoft
  • @envisagenics